What would Mad Men make of the digital era?
November 18, 2010Medical Communications Creative Lynx, advertising, digital marketing
Sharp-suited creative director Don Draper from AMC’s television series ‘Mad Men’, in conversation with Creative Lynx’s David Hunt … DAVID: …
Genzyme courting ‘white knight’ bid from Takeda
November 18, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, Takeda, pharma mergers
Genzyme is in talks with Takeda to secure a ‘white knight’ bid that would prevent Sanofi-Aventis from taking over the …
CP Pharma gets FDA warning for Wrexham facility
November 18, 2010Manufacturing and Production CP Pharmaceuticals, FDA, FDA warning letter, Wockhardt, manufacturing compliance, pharma manufacturing
UK drugmaker CP Pharmaceuticals is the latest to receive a warning letter from the FDA for failing to meet standards …
New ABPI Code published
November 17, 2010Medical Communications, Sales and Marketing 2011 ABPI Code, ABPI, ABPI Code of Practice, PMCPA, pharma marketing, pharma sales
The ABPI has published the 2011 version of its Code of Practice for UK pharmaceutical companies, with copies now available …
Government directs councils to supply personal health budgets
November 17, 2010Sales and Marketing big society, government, healthcare, reforms
The government announced this week that it expects local councils to provide personal health budgets to a million eligible people …
Roche set to cut 4,800 jobs worldwide
November 17, 2010Manufacturing and Production, Research and Development, Sales and Marketing Jobs, Roche, avastin, cuts, taspoglutide
Roche’s ‘Operational Excellence’ programme will see it cut 6% of its global workforce over the next two years. The initiative …
Pfizer establishes new US research network
November 17, 2010Research and Development, Sales and Marketing BiodiscoveryTherapeutics, MedImmune, Pfizer
Pfizer has established a new network of research partnerships with its Global Centers for Therapeutic Innovation. The Centers is a …
Government drops Dr Foster Intelligence
November 17, 2010Sales and Marketing Dr Foster Intelligence, White paper, government, reforms
The government is set to drop the public-private partnership it currently has with Dr Foster Intelligence, its key provider information …
Europe’s neurologists unfamiliar with emerging Alzheimer’s drugs
November 17, 2010Research and Development, Sales and Marketing Alzheimer's, Aricept, Decision Resources, Europe, Pfizer
A survey of neurologists in Europe has shown only a minority are aware of late stage drugs being developed to …
Digital Pharma: Diabetes video goes viral
November 16, 2010Medical Communications, Sales and Marketing Diabetes Hands Foundation, Digital Pharma blog, Roche, diabetes, viral video, youtube
An online video encouraging diabetics to test their blood sugar levels has passed 117,000 views on YouTube in just over …
First patient treated in groundbreaking stem cell trial
November 16, 2010Research and Development GRNOPC1, Geron, PISCES, Pilot Investigation of Stem Cells in Stroke, ReN001, ReNeuron, Stem cells, ischaemic stroke, stroke
The first patient has been treated in a groundbreaking stem cell trial as part of a bid to develop a …
FDA approves Eisai breast cancer drug Halaven
November 16, 2010Sales and Marketing Cancer, Eisai, FDA, Halaven, Xeloda, breast cancer, eribulin mesylate, metastatic breast cancer
The FDA has approved Eisai’s advanced breast cancer drug Halaven for use in heavily pre-treated breast cancer patients. Halaven (eribulin …
PolyTherics appoints Dr John Burt chief business officer
November 16, 2010Manufacturing and Production, Research and Development Dr John Burt, PolyTherics, appointment, manufacturing and production, protein engineering, research and development
UK protein engineering company PolyTherics has appointed Dr John Burt as chief business officer. He was previously chief executive of …
Value-based pricing no ‘magic bullet’ – ABPI
November 16, 2010Sales and Marketing ABPI, Dr Richard Barker, NHS drug sales, PPRS, UK medicines pricing, value-based pricing
UK pharma association the ABPI has warned that the government’s planned value-based pricing system for medicines will not necessarily save …
Rising Angel plans manufacturing expansion
November 16, 2010Manufacturing and Production Andrew Carver, Angel Biotechnology, GMP, Good Manufacturing Practice, Pentlands Science Park, Susan McKee, contract manufacturing
Scottish contract manufacturing company Angel Biotechnology plans to increase its capacity by taking over a mothballed production facility after signing …
FDA slaps import ban on Claris Life Sciences
November 16, 2010Manufacturing and Production Ahmedabad, Claris Life Sciences, FDA, GMP, GMP violations, Good Manufacturing Practice, Ranbaxy Pharmaceuticals, manufacturing compliance
Indian drugmaker Claris Life Sciences has been prohibited from importing products into the US after manufacturing quality problems emerged at …
Chiltern Launches “Chiltern Safe”, a Comprehensive Global Trial Master File Management Solution
November 15, 2010Research and Development
“Chiltern SAFE is revolutionizing records management for clinical trials”, stated Sarah Hitching, Chiltern Director, Records Management. “This complete electronic Trial …
Pfizer’s John Proctor moves to Quintiles
November 15, 2010Sales and Marketing John Proctor, Pfizer, Quintiles, UK, appointment, sales and marketing
Quintiles has appointed the former head of Pfizer Health Solutions to lead its own Health Management Solutions (HMS) business. As …
When should pharma leaders trust their gut instinct?
November 15, 2010Business Services, Sales and Marketing decision making, leadership, management
One of the most important questions facing leaders is when they should trust their gut instincts. Our work at McKinsey …
GSK partners with Brazil’s Fiocruz on tropical disease research
November 15, 2010Research and Development Chagas disease, Fiocruz, GSK, GSK’s Tres Cantos Medicines Development Campus, GlaxoSmithKline, Oswald Cruz Foundation, leishmaniasis
GlaxoSmithKline and the Brazil-based Oswald Cruz Foundation (Fiocruz) are to research and develop new medicines for tropical diseases Chagas and …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
